MedicaidPrior AuthMedium impact
Attention All Providers: Healthcare Common Procedure Coding System (HCPCS) Code Q5126 Open for Billing
Nevada Medicaid·NV · Oncology·Billing & Coding
Effective date
Oct 1, 2024
We identified it
Jun 21, 2026
Summary
Nevada Medicaid is opening HCPCS code Q5126 (bevacizumab-maly biosimilar injection) for billing effective January 1, 2023, with prior authorization required starting October 1, 2024. Previously denied claims with error code 3001 will be automatically reprocessed.
Action Required
By October 1, 2024: Billing team must update system to require prior authorization for HCPCS code Q5126 (bevacizumab-maly injection). Ensure NDC codes are included on all Q5126 claims. Monitor remittance advice for automatically reprocessed claims that previously denied with error code 3001.